Should You Buy the Dip in HDFC Bank?

NYSE: HDB | HDFC Bank Limited  News, Ratings, and Charts

HDB – The shares of India’s largest private-sector bank, HDFC Bank (HDB), have lost momentum over the past year due to increasing investor concerns surrounding the bank’s growing non-performing assets. However, with stable profit margins and strengthening credit card offerings, will HDB’s stock regain its momentum this year? Read more to learn our view.

HDFC Bank Limited (HDB) in Mumbai is the largest private-sector bank in India, with a presence in more than 2,900 cities in the country. The bank operates in five segments: Treasury; Retail Banking; Wholesale Banking; Other Banking business; and Unallocated.

Shares of HDB have slumped 3.8% in price over the past year because the bank’s increasing non-performing assets have been alarming investors. 

Furthermore, the bank’s profit margins came in shy of analyst expectations in its fiscal second quarter, ended June 30, 2021, causing investors to recoil from the bank.

So, here is what could shape HDB’s performance in the near term:

Increasing Non-Performing Assets

HDB’s gross non-performing assets increased 24.1% year-over-year to Rs.170.99 billion ($2.30 billion) for its fiscal second quarter, ended June 30, 2021. Its NPAs came in at Rs.5.49 billion ($73.75 million), up 67.3% from the same period last year. And its percent of gross NPAs to gross advances increased 11 basis points from the prior-year quarter to 1.47%. In comparison, its percent of net NPAs to net advances increased 15 basis points from the year-ago value to 0.48%.

Stable Profits

HDB’s total income increased 6.7% year-over-year to Rs. 367.71 billion ($4.94 billion). Its net profit increased 16.1% from the same period last year to Rs.77.30 billion ($1.04 billion). However, HDB’s quarterly profit fell short of the Rs 80.72 billion ($1.08 billion) consensus estimate.

Legal Investigation

New York-based law firm Pomerantz LP is currently investigating whether certain officers and/or directors of HDB have engaged in securities fraud or other unlawful practices. This comes in after the bank reported an increase in its non-performing assets and declining asset quality in its fiscal second quarter, ended June 30, 2021.

Stretched Valuation

In terms of forward non-GAAP P/E, HDB is currently trading at 25.22x, which is 114.2% higher than the 11.78x industry average. Its 1.15 forward non-GAAP PEG ratio is 18.8% higher than the 0.97 industry average.

In addition, the stock’s 8.29 forward Price/Sales multiple is 134% higher than the 3.54 industry average. And its 3.78 trailing-12-month Price/Book and Price/Cash Flow multiples of 3.78 and 18.13, respectively, compare with the 1.31 and 8.97 industry averages.

POWR Ratings Reflect Uncertainty

HDB has an overall C rating, which equates to Neutral in our proprietary POWR Ratings system. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree.

HDB has a C grade for Growth. The bank’s trailing-12-month revenues increased 8.1% year-over-year. However, the company’s trailing-12-month ROE declined 7.1% from the same period last year, in sync with the Growth grade.

Of 97 stocks in the C-rated Foreign Banks industry, HDB is ranked #52.

In total, we rate HDB on eight distinct levels. Beyond what we have stated above, we have rated HDB for Momentum, Sentiment, Value, Stability, and Quality here.

Bottom Line

The Reserve Bank of India (RBI) imposed a ban on HDB to prevent it from issuing credit cards for eight months toward the end of 2020, citing frequent outages. This caused HBD to lose its position as India’s biggest credit card issuer. However, the central bank lifted the ban last August, following which HDB announced its plans to issue 300,000 cards through 2022. This should allow HDB to regain its position as the leading credit card issuer in the country, thereby boosting its profit margins. However, we think investors should wait until the bank’s NPAs fall before investing in it.

How Does HDFC Bank Limited (HDB) Stack Up Against its Peers?

While HDB has a C rating in our proprietary rating system, one might want to consider looking at its industry peers, OFG Bancorp (OFG), Barclays PLC (BCS), and UBS Group AG (UBS), which have a B (Buy) rating.

Want More Great Investing Ideas?

100 Best Stocks for 2022

3 Stocks to DOUBLE This Year

How to Trade Options with the POWR Ratings

9 “Must Own” Growth Stocks


HDB shares were trading at $69.30 per share on Friday afternoon, up $1.20 (+1.76%). Year-to-date, HDB has gained 6.50%, versus a -1.54% rise in the benchmark S&P 500 index during the same period.

About the Author: Aditi Ganguly

Aditi is an experienced content developer and financial writer who is passionate about helping investors understand the do’s and don'ts of investing. She has a keen interest in the stock market and has a fundamental approach when analyzing equities. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
HDBGet RatingGet RatingGet Rating
OFGGet RatingGet RatingGet Rating
BCSGet RatingGet RatingGet Rating
UBSGet RatingGet RatingGet Rating

Most Popular Stories on

3 Safe Gold Stocks Pointing to Buy

Gold is often considered a safe-haven asset during economic uncertainty and is used as a hedge against inflation. Given a long-term robust outlook for gold on solid demand and rising prices, fundamentally sound gold stocks Alamos (AGI), Harmony Gold Mining (HMY), and Eldorado Gold (EGO) could be solid buys for steady returns. Keep reading…

Why the Bull Market is Still in Charge?

It’s been nearly 2 months that the S&P 500 (SPY) has been mired in a trading range. That is why investment veteran Steve Reitmeister shares his latest insights to explain why a bull market is still in place...and how to target the best stocks and ETFs for the days ahead. Read on for the full story below...

3 Biotechs with Massive Growth Potential

These three biotech stocks have massive growth opportunities on the horizon, and could add a huge boost to any portfolio. They play in some of the most in demand markets on the planet, and have track records of finding ways to introduce products into those markets to capture big profits. Novo Nordisk (NVO), Regeneron (REGN) and Corcept Therapeutics (CORT) are deserving of a very close look right now.

Coca-Cola (KO) and 2 More Beverage Stocks – Buy or Sell?

The beverage industry exhibits a bright outlook due to evolving consumer preferences amid rising health consciousness. Therefore, let us analyze whether leading beverage stocks Coca-Cola (KO), National Beverage (FIZZ), and Celsius Holdings (CELH) are Buy, Hold, or Sell now. Read more...

The ODD Story Behind Thursday’s BIG Stock Rally

We have all been worried about what high inflation will do to the economy and stock market. And yet on Thursday inflation spiked again, yet amazingly the S&P 500 (SPY) had a great session. Investment veteran Steve Reitmeister shares the reasons why in his new market outlook with trading plan and top picks. Read on below for more...

Read More Stories

More HDFC Bank Limited (HDB) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All HDB News